Time course of intermittent hypoxia-induced impairments in resistance artery structure and function

Respiratory Physiology and Neurobiology

Volumn 170, Issue 2, 2010, Pages 157-163

  Philippi, Nathan R ^a   Bird, Cynthia E ^a   Marcus, Noah J ^b   Olson, E Burt ^a   Chesler, Naomi C ^c   Morgan, Barbara J ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Madison   (United States)

Author keywords

Fibrillar collagens; Isoprostanes; Vascular endothelium; Vasodilation

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; COLLAGEN; ISOPROSTANE DERIVATIVE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; DRUG EFFECT; FUNCTIONAL ASSESSMENT; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPONSE TIME; STRUCTURE ACTIVITY RELATION; TIME PERCEPTION; VASODILATATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; ARTERIES; CHRONIC DISEASE; COLLAGEN; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; ISOPROSTANES; MALE; MUSCLE, SKELETAL; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OXYGEN; PARTIAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 75149139879     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2009.12.003     Document Type: Article

References (45)

1. Alonso-Fernandez A., Garcia-Rio F., Arias M.A., Hernanz A., de la Pena M., Pierola J., Barcelo A., Lopez-Collazo E., and Agusti A. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64 (2009) 581-586
2. Baguet J.P., Hammer L., Levy P., Pierre H., Launois S., Mallion J.M., and Pepin J.L. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128 (2005) 3407-3412
3. Becker H.F., Jerrentrup A., Ploch T., Grote L., Penzel T., Sullivan C.E., and Peter J.H. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 (2003) 68-73
4. Ben-Yosef Y., Lahat N., Shapiro S., Bitterman H., and Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res. 90 (2002) 784-791
5. Bleeke T., Zhang H., Madamanchi N., Patterson C., and Faber J.E. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ. Res. 94 (2004) 37-45
6. Carlson J.T., Hedner J., Elam M., Ejnell H., Sellgren J., and Wallin B.G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 (1993) 1763-1768
7. Carlson J.T., Rangemark C., and Hedner J.A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J. Hypertens. 14 (1996) 577-584
8. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., and Barnes P.J. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124 (2003) 1386-1392
9. Cross M.D., Mills N.L., Al-Abri M., Riha R., Vennelle M., Mackay T.W., Newby D.E., and Douglas N.J. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 63 (2008) 578-583
10. Drager L.F., Bortolotto L.A., Figueiredo A.C., Silva B.C., Krieger E.M., and Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 131 (2007) 1379-1386
11. Fletcher E.C., Lesske J., Qian W., Miller III C.C., and Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19 (1992) 555-561
12. Gonzalez N.C., Allen J., Schmidt E.J., Casillan A.J., Orth T., and Wood J.G. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2285-H2294
13. Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., and Lam W.K. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med. 162 (2000) 2166-2171
14. Ip M.S., Tse H.F., Lam B., Tsang K.W., and Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am. J. Respir. Crit. Care Med. 169 (2004) 348-353
15. Jacob M.P., Badier-Commander C., Fontaine V., Benazzoug Y., Feldman L., and Michel J.B. Extracellular matrix remodeling in the vascular wall. Pathol. Biol. (Paris) 49 (2001) 326-332
16. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11 (1979) 447-455
17. Kato M., Roberts-Thomson P., Phillips B.G., Haynes W.G., Winnicki M., Accurso V., and Somers V.K. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102 (2000) 2607-2610
18. Kohler M., Craig S., Nicoll D., Leeson P., Davies R.J., and Stradling J.R. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 178 (2008) 984-988
19. Kraiczi H., Caidahl K., Samuelsson A., Peker Y., and Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119 (2001) 1085-1091
20. Kukreja R.C., and Hess M.L. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26 (1992) 641-655
21. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., and Celermajer D.S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61 (2006) 491-495
22. Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog. Cardiovasc. Dis. 51 (2009) 303-312
23. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004) 123-128
24. Marcus N.J., Olson Jr. E.B., Bird C.E., Philippi N.R., and Morgan B.J. Time-dependent adaptation in the hemodynamic response to hypoxia. Respir. Physiol. Neurobiol. 165 (2009) 90-96
25. Marcus N.J., Li Y.L., Bird C.B., Olson E.B., Smith S.S., Sorenson K.I., Schultz H.D., and Morgan B.J. Chronic intermittent hypoxia alters chemoreflex control of lumbar sympathetic nerve activity and carotid body protein expression. FASEB J. 23 (2009) 1008.1
26. Milne G.L., Musiek E.S., and Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10 Suppl. 1 (2005) S10-S23
27. Minoguchi K., Yokoe T., Tazaki T., Minoguchi H., Tanaka A., Oda N., Okada S., Ohta S., Naito H., and Adachi M. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 172 (2005) 625-630
28. Nacher M., Serrano-Mollar A., Farre R., Panes J., Segui J., and Montserrat J.M. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir. Physiol. Neurobiol. 155 (2007) 93-96
29. Nieto F.J., Herrington D.M., Redline S., Benjamin E.J., and Robbins J.A. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am. J. Respir. Crit. Care Med. 169 (2004) 354-360
30. Peng Y.J., and Prabhakar N.R. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J. Appl. Physiol. 94 (2003) 2342-2349
31. Phillips C., Hedner J., Berend N., and Grunstein R. Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 28 (2005) 604-609
32. Phillips C., Yee B., Yang Q., Villaneuva A., Hedner J., Berend N., and Grunstein R. Effects of CPAP treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central blood pressure. Chest 134 (2008) 94-100
33. Phillips S.A., Olson E.B., Lombard J.H., and Morgan B.J. Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J. Appl. Physiol. 100 (2006) 1117-1123
34. Phillips S.A., Olson E.B., Morgan B.J., and Lombard J.H. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H388-H393
35. Rader D.J., and FitzGerald G.A. State of the art: atherosclerosis in a limited edition. Nat. Med. 4 (1998) 899-900
36. Reboul C., Gibault A., Tanguy S., Dauzat M., and Obert P. Alteration of endothelium-mediated vasodilator response in the rat hindlimb vasculature consecutive to chronic hypoxic stress: NO and EDHF involvement. Vascul. Pharmacol. 51 (2009) 154-161
37. Rizzoni D., Paiardi S., Rodella L., Porteri E., De C.C., Rezzani R., Boari G.E., Zani F., Miclini M., Tiberio G.A., Giulini S.M., Rosei C.A., Bianchi R., and Rosei E.A. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 91 (2006) 2638-2642
38. Schiffrin E.L., and Hayoz D. How to assess vascular remodelling in small and medium-sized muscular arteries in humans. J. Hypertens. 15 (1997) 571-584
39. Schulz R., Mahmoudi S., Hattar K., Sibelius U., Olschewski H., Mayer K., Seeger W., and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am. J. Respir. Crit. Care Med. 162 (2000) 566-570
40. Stenmark K.R., Gerasimovskaya E., Nemenoff R.A., and Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122 (2002) 326S-334S
41. Tahawi Z., Orolinova N., Joshua I.G., Bader M., and Fletcher E.C. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J. Appl. Physiol. 90 (2001) 2007-2013
42. Tanriverdi H., Evrengul H., Kara C.O., Kuru O., Tanriverdi S., Ozkurt S., Kaftan A., and Kilic M. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 73 (2006) 741-750
43. Tsioufis C., Thomopoulos K., Dimitriadis K., Amfilochiou A., Tousoulis D., Alchanatis M., Stefanadis C., and Kallikazaros I. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J. Hypertens. 25 (2007) 141-146
44. Weiss J.W., Liu M.D., and Huang J. Sleep apnoea & hypertension: physiological bases for a causal relation: physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp. Physiol. 92 (2007) 21-26
45. Wilkinson I.B., and McEniery C.M. Arterial stiffness, endothelial function and novel pharmacological approaches. Clin. Exp. Pharmacol. Physiol. 31 (2004) 795-799